Andrew Rubinstein joined Paul Capital in 2007, and is primarily responsible for negotiating, structuring, and executing investments. Mr. Rubinstein has over 10 years of financial, operating and transaction experience, both domestic and international. Prior to joining Paul Capital, he was CEO of Microban International, Ltd. a multinational business focused on antimicrobial technologies. Mr. Rubinstein had previously worked as an investment banker at Merrill Lynch & Co. in the Financial Sponsors Group. He earned a B.A. from the University of Pennsylvania, a J.D. from New York University School of Law, and an M.B.A. from New York University Stern School of Business.